Zelenectide pevedotin

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameZelenectide pevedotin
Drug Alias NameBT-8009BCY-8245
ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)Small molecules > Synthetic peptide > Circular polypeptide
Mechanisms of ActionTubulin inhibitorsNectin-4 binders
TargetsNectin-4Tubulin
Therapy Area/IndicationsSolid tumoursUrinary Bladder NeoplasmsCarcinoma, Non-Small-Cell Lung +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[21] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBicycle Tx Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBicycle Tx Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursUrinary Bladder NeoplasmsCarcinoma, Non-Small-Cell Lung +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A